Editas Medicine
(EDIT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 62,841 | 10,749 | 5,723 | 12,284 | 3,848 |
| Gross Profit | 62,841 | 10,749 | 5,723 | 12,284 | 3,848 |
| Operating Expenses | 53,852 | 42,088 | 52,339 | 51,707 | 38,436 |
| Operating Income | 8,989 | -31,339 | -46,616 | -39,423 | -34,588 |
| Interest Expense | 1,396 | -7,175 | -1,559 | 4,092 | 33 |
| Other Income | 226 | 592 | 7,333 | 5,745 | 1,680 |
| Pre-tax Income | 7,819 | -23,572 | -37,724 | -37,770 | -32,941 |
| Net Income Continuous | 7,819 | -23,572 | -37,724 | -37,770 | -32,941 |
| Net Income | $7,819 | $-23,572 | $-37,724 | $-37,770 | $-32,941 |
| EPS Basic Total Ops | 0.13 | -0.43 | -0.69 | -0.73 | -0.66 |
| EPS Basic Continuous Ops | 0.13 | -0.43 | -0.69 | -0.73 | -0.66 |
| EPS Diluted Total Ops | 0.12 | -0.43 | -0.69 | -0.73 | -0.66 |
| EPS Diluted Continuous Ops | 0.12 | -0.43 | -0.69 | -0.73 | -0.66 |
| EBITDA(a) | $10,096 | $-30,468 | $-45,818 | $-38,641 | $-33,861 |